Elon Musk Seeks $134 Billion in Lawsuit Against OpenAI and Microsoft Over Alleged Wrongful Gains 
Rio Tinto and BHP Agree to Explore Major Iron Ore Collaboration in Pilbara 
Toyota Industries Buyout Faces Resistance as Elliott Rejects Higher Offer 
Jamie Dimon Signals Possible Five More Years as JPMorgan CEO Amid Ongoing Succession Speculation 
China Considers New Rules to Limit Purchases of Foreign AI Chips Amid Growing Demand 
Federal Judge Clears Way for Jury Trial in Elon Musk’s Fraud Lawsuit Against OpenAI and Microsoft 
Microsoft Strikes Landmark Soil Carbon Credit Deal With Indigo Carbon to Boost Carbon-Negative Goal 
Boeing Reaches Tentative Settlement With Canadian Victim’s Family in 737 MAX Crash Lawsuits 
TikTok Expands AI Age-Detection Technology Across Europe Amid Rising Regulatory Pressure 
Anthropic Appoints Former Microsoft Executive Irina Ghose to Lead India Expansion 
Boeing Reaches Tentative Labor Deal With SPEEA Workers After Spirit AeroSystems Acquisition 
Taiwan Issues Arrest Warrant for OnePlus CEO Over Alleged Illegal Recruitment Activities 
BYD Shares Rise in Hong Kong on Reports of Battery Supply Talks With Ford 
U.S. Moves to Expand Chevron License and Control Venezuelan Oil Sales 
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio 
China’s AI Models Narrow the Gap With the West, Says Google DeepMind CEO 
U.S. Lawmakers Raise Alarm Over Trump Approval of Nvidia AI Chip Sales to China 
NORCROSS, Ga., April 11, 2017 -- Immucor, Inc., a global leader in transfusion and transplantation diagnostics, today announced that it will hold a conference call with debt investors on Friday, April 21, 2017 at 11:00 a.m. ET to discuss its fiscal 2017 third quarter results.
Interested debt investors and analysts should contact Immucor Investor Relations at [email protected] or 770-441-2051 for details.
About Immucor
Founded in 1982, Immucor is a global leader in transfusion and transplantation diagnostics that facilitate patient-donor compatibility. Our mission is to ensure that patients in need of blood, organs or stem cells get the right match that is safe, accessible and affordable. With the right match, we can transform a life together. For more information on Immucor, please visit our website at www.immucor.com.
CONTACT: Michele Howard 770-441-2051
